207 related articles for article (PubMed ID: 32174892)
1. Management Strategies for POSEIDON Group 2.
Sunkara SK; Ramaraju GA; Kamath MS
Front Endocrinol (Lausanne); 2020; 11():105. PubMed ID: 32174892
[TBL] [Abstract][Full Text] [Related]
2. Cumulative live birth rates in low-prognosis women.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
[TBL] [Abstract][Full Text] [Related]
3. Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.
Liu X; Xu J; Bi L; Liu P; Jiao X
Front Endocrinol (Lausanne); 2021; 12():790160. PubMed ID: 34925245
[TBL] [Abstract][Full Text] [Related]
4. Predictive Factors for Live Birth in Fresh
Li F; Ye T; Kong H; Li J; Hu L; Jin H; Guo Y; Li G
Front Endocrinol (Lausanne); 2021; 12():630832. PubMed ID: 33967954
[TBL] 
